Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-386
Closed -$120K 135
2025
Q1
$120K Sell
386
-117
-23% -$34.5K 0.04% 154
2024
Q4
$131K Buy
503
+101
+25% +$30K 0.04% 158
2024
Q3
$129K Buy
402
+1
+0.2% +$327 0.04% 161
2024
Q2
$125K Buy
401
+16
+4% +$4.7K 0.04% 160
2024
Q1
$109K Buy
385
+1
+0.3% +$293 0.04% 171
2023
Q4
$111K Sell
384
-179
-32% -$48.8K 0.04% 168
2023
Q3
$151K Buy
563
+1
+0.2% +$250 0.07% 143
2023
Q2
$125K Buy
562
+371
+194% +$86.1K 0.05% 151
2023
Q1
$46.1K Buy
191
+1
+0.5% +$245 0.02% 229
2022
Q4
$49.9K Sell
190
-148
-44% -$39.7K 0.03% 222
2022
Q3
$76K Sell
338
-264
-44% -$64K 0.04% 179
2022
Q2
$147K Sell
602
-367
-38% -$89.9K 0.07% 141
2022
Q1
$234K Hold
969
0.1% 129
2021
Q4
$218K Buy
969
+5
+0.5% +$1.05K 0.09% 140
2021
Q3
$205K Buy
+964
New +$222K 0.09% 143
2020
Q1
Sell
-432
Closed -$104K 131
2019
Q4
$104K Buy
+432
New +$95.2K 0.07% 188

Other funds holding AMGN

PSI Advisors's AMGN Position: Q2 2025 in Review

PSI Advisors sold out of Amgen (AMGN) in Q2 2025, closing a stake of 386 shares — an estimated $120K sold.

PSI Advisors first reported a position in AMGN in Q4 2019 and held it in 16 quarters. The position peaked at $234K in Q1 2022. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • PSI Advisors reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • PSI Advisors sold 386 Amgen shares in Q2 2025, an estimated $120K.
  • PSI Advisors first reported a position in Amgen in Q4 2019 and held it in 16 quarters.
  • PSI Advisors's Amgen position peaked at $234K in Q1 2022.
  • 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on PSI Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.